
Kiniksa Announces FDA Approval of Arcalyst (rilonacept) for Recurrent Pericarditis
HAMILTON, Bermuda, March 18, 2021 (GLOBE NEWSWIRE) — Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) (Kiniksa), a biopharmaceutical company with a portfolio […]
HAMILTON, Bermuda, March 18, 2021 (GLOBE NEWSWIRE) — Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) (Kiniksa), a biopharmaceutical company with a portfolio […] FDA Approves Zegalogue (dasiglucagon) Injection for the Treatment of Severe Hypoglycemia in People with Diabetes Copenhagen, DK and Boston, MA, […] Can’t see the audio player? Click here to listen on SoundCloud. For the first time since its enactment in 2010, the […] NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. PIAX PLUS ASPIRIN 75/100 TABLETS CMI v1 […] NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. FLUCONAZOLE APOTEX Fluconazole Consumer Medicine Information What […] NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. PANADOL® SINUS RELIEF ORIGINAL FORMULA ORIGINAL FORMULA […]Medications
Kiniksa Announces FDA Approval of Arcalyst (rilonacept) for Recurrent Pericarditis
FDA Approves Zegalogue
KHN’s ‘What the Health?’: Expanding the ACA in an Unpredicted Way
Piax Plus Asprin
Fluconazole APOTEX
Panadol Sinus Relief Original Formula
Copyright © 2023